Press

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight

The CD40/CD40L inhibitors market is experiencing steady growth driven by increasing research into autoimmune diseases, organ transplantation, and cancer immunotherapy. The rising prevalence of rheumatoid arthritis, systemic lupus erythematosus, and other inflammatory conditions is boosting demand for targeted immune-modulating therapies. Additionally, advancements in biologics and monoclonal antibody development are expanding the therapeutic pipeline. LAS VEGAS, […]

CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight Read Post »

Press
Dickeys Barbecue Logo

Dickey’s Barbecue Pit Responds to Frivolous, False Lawsuit Claims

DALLAS, July 24, 2025 /PRNewswire/ — Dickey’s Barbecue Restaurants, Inc. has issued a statement in response to a lawsuit filed by a former Houston franchisee, asserting that the allegations are false, without merit and misrepresent the company’s franchise model. The success of Dickey’s Barbecue Pit has been built on a foundation of integrity and a strong

Dickey’s Barbecue Pit Responds to Frivolous, False Lawsuit Claims Read Post »

Press
KP1 DBJ

DELTA DENTAL OF COLORADO NAMES KEITH W. PHILLIPS CHIEF FINANCIAL OFFICER

Phillips brings 20+ years of experience in finance across various industries DENVER, July 24, 2025 /PRNewswire/ — Today, Delta Dental of Colorado (DDCO) announced the hiring of Keith W. Phillips as its chief financial officer starting August 11, 2025. In this role, he will assume critical responsibility for overseeing the financial health and strategy of

DELTA DENTAL OF COLORADO NAMES KEITH W. PHILLIPS CHIEF FINANCIAL OFFICER Read Post »

Press
Elanco Logo

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

The European Commission’s Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind., July 24, 2025 /PRNewswire/ — Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has received

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs Read Post »

Press
Aleut UCOR Award

Aleut Recognized by UCOR for Exceptional Small Business Performance

OAK RIDGE, Tenn., July 24, 2025 /PRNewswire/ —  Aleut Demolition Services LLC (Aleut), a subsidiary of Aleut Federal, LLC (Aleut Federal), has been honored with a 2025 Small Business Award by United Cleanup Oak Ridge (UCOR) for outstanding performance in support of the Department of Energy’s (DOE) Oak Ridge Office of Environmental Management (OREM). The

Aleut Recognized by UCOR for Exceptional Small Business Performance Read Post »

Press
Aspiri Enterprises Ray Aspiri

Boise to welcome up to 50,000 for Basque festival

BOISE, Idaho, July 24, 2025 /PRNewswire/ — Every five years, Idaho’s state capital becomes the Basque capital of America as up to 50,000 of the unique European ethnic group of that descent descend on Boise for Jaialdi, which means “festival” in the Basques’ Euskara language. Seattleite Ray Aspiri, a career entrepreneur-investor and managing director of Aspiri

Boise to welcome up to 50,000 for Basque festival Read Post »

Press

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight

The market for B7-H4 targeted therapies is projected to experience substantial growth in the coming years, driven by a rising incidence of cancer diagnoses, growing awareness of the B7-H4 biomarker, and an expanding pipeline of B7-H4-targeted treatments currently in clinical development. LAS VEGAS, July 24, 2025 /PRNewswire/ — DelveInsight’s B7-H4 Targeting Therapies Market Size, Target

B7-H4 Targeting Therapies Market Growth Set to Accelerate Across the 7MM During the Study Period (2025-2040) with Advances in Immunotherapy | DelveInsight Read Post »

Press
Scroll to Top